TOLERABILITY
Clinical trials for TOLERABILITY explained in plain language.
Never miss a new study
Get alerted when new TOLERABILITY trials appear
Sign up with your email to follow new studies for TOLERABILITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New probiotic passes first safety test in small human study
Symptom relief CompletedThis completed study tested whether an oral probiotic called Streptococcus salivarius eK12 is safe and well-tolerated in healthy adults. Researchers gave 29 participants either the probiotic or a placebo and monitored for side effects, changes in vital signs, and blood test resul…
Matched conditions: TOLERABILITY
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Jun 26, 2026 13:42 UTC
-
Tiny study checks if novel bacterium is safe for people
Knowledge-focused CompletedThis completed trial tested whether a heat-killed bacterium called KGA-10 (also known as NeuroAlly) is safe and tolerable for healthy adults. Eight participants took either KGA-10 or a placebo daily for one week. Researchers tracked side effects and satisfaction using surveys. Th…
Matched conditions: TOLERABILITY
Phase: NA • Sponsor: Kioga Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug Y-3 tested in healthy people for first time in the U.S.
Knowledge-focused CompletedThis early-stage study tested a single dose of the experimental drug Y-3 in 20 healthy adults to see if it is safe and how the body processes it. Participants received either 40 mg, 60 mg, or a placebo. The study is complete and focused on gathering basic safety and drug-level in…
Matched conditions: TOLERABILITY
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC